@the_news_21
India is struggling with Covid-19 cases as the country is registering around 4 lakh infected patients daily. So vaccines have become a hope, however, India only has three vaccines which are in use currently.
Now, reports indicate that a fourth vaccine could soon join the fight against COVID-19 in India.
Ahmedabad based drug firm Zydus Cadila believes that its three dose vaccine, ZyCoV-D could soon receive emergency usage approval in India. According to reports that quote company MD Dr Sharvil Patel, Zydus is likely to apply for emergency use authorisation this month and plans to produce one crore doses of the vaccine per month. The vaccine, he told India Today, is getting “very close to approval”.
Earlier this year, in January, the Drugs Controller General of India (DCGI) approved the initiation of initiate Phase III clinical trials of the vaccine. The Ministry had said that Zydus Cadila completed Phase-I/II clinical trials of this DNA Vaccine candidate, in India, in more than 1,000 participants and interim data indicated that the vaccine is safe and immunogenic when three doses were administered intradermally.
According to Patel, the company hopes to get the efficacy data in mid-May. “As soon as we see strong efficacy which correlates to the vaccine’s strong immunogenicity in Phase 2, we will file for emergency use authorization. We hope to produce a good quantity of the vaccine from July onwards to make sure it is available to the people,” he told the publication.
